These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11549104)

  • 21. Multiple-dose pharmacokinetics confirm no accumulation and dose proportionality of the novel promotile drug tegaserod (HTF 919).
    Appel-Dingemanse S; Hirschberg Y; Osborne S; Pommier F; McLeod J
    Eur J Clin Pharmacol; 2001 Mar; 56(12):889-91. PubMed ID: 11317476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I pilot study of the effects of trovafloxacin (CP-99,219) on the pharmacokinetics of theophylline in healthy men.
    Dickens GR; Wermeling D; Vincent J
    J Clin Pharmacol; 1997 Mar; 37(3):248-52. PubMed ID: 9089427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.
    Dadashzadeh S; Tajerzaden H
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):77-83. PubMed ID: 11554438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of pharmacokinetics of theophylline by antofloxacin, a novel 8-amino-fluoroquinolone, in humans.
    Liu L; Pan X; Liu HY; Liu XD; Yang HW; Xie L; Cheng JL; Fan HW; Xiao DW
    Acta Pharmacol Sin; 2011 Oct; 32(10):1285-93. PubMed ID: 21892200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of cytochrome P450 1A2 interaction effect of ABT-761 on the pharmacokinetics of theophylline.
    Wong SL; Cavanaugh JH; Qian J; Hansen R; Awni WM
    Am J Ther; 1998 Sep; 5(5):303-6. PubMed ID: 10099073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.
    Thalamas C; Taylor A; Brefel-Courbon C; Eagle S; Fitzpatrick K; Rascol O
    Eur J Clin Pharmacol; 1999 Jun; 55(4):299-303. PubMed ID: 10424323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No pharmacokinetic or pharmacodynamic interaction between theophylline and the leukotriene biosynthesis inhibitor BAY x 1005.
    Groen H; Moesker HL; Leeuwenkamp OR; Sollie FA; Jonkman JH
    J Clin Pharmacol; 1996 Jul; 36(7):639-46. PubMed ID: 8844447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of theophylline metabolism by aciclovir.
    Maeda Y; Konishi T; Omoda K; Takeda Y; Fukuhara S; Fukuzawa M; Ohune T; Tsuya T; Tsukiai S
    Biol Pharm Bull; 1996 Dec; 19(12):1591-5. PubMed ID: 8996645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of meal timing not critical for the pharmacokinetics of tegaserod (HTF 919).
    Zhou H; Khalilieh S; Lau H; Guerret M; Osborne S; Alladina L; Laurent AL; McLeod JF
    J Clin Pharmacol; 1999 Sep; 39(9):911-9. PubMed ID: 10471981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro metabolism of tegaserod in human liver and intestine: assessment of drug interactions.
    Vickers AE; Zollinger M; Dannecker R; Tynes R; Heitz F; Fischer V
    Drug Metab Dispos; 2001 Oct; 29(10):1269-76. PubMed ID: 11560869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of pharmacokinetic interactions between cilomilast and theophylline or smoking in healthy volunteers.
    Murdoch RD; Zussman B; Schofield JP; Webber DM
    J Clin Pharmacol; 2004 Sep; 44(9):1046-53. PubMed ID: 15317832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
    Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of grapefruit juice on the pharmacokinetics of theophylline in healthy male volunteers.
    Gupta MC; Garg SK; Badyal D; Malhotra S; Bhargava VK
    Methods Find Exp Clin Pharmacol; 1999 Dec; 21(10):679-82. PubMed ID: 10702965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects.
    Morganroth J; Rüegg PC; Dunger-Baldauf C; Appel-Dingemanse S; Bliesath H; Lefkowitz M
    Am J Gastroenterol; 2002 Sep; 97(9):2321-7. PubMed ID: 12358251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of xanthine oxidase inhibition by febuxostat on the pharmacokinetics of theophylline.
    Tsai M; Wu JT; Gunawardhana L; Naik H
    Int J Clin Pharmacol Ther; 2012 May; 50(5):331-7. PubMed ID: 22541837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of zileuton on theophylline pharmacokinetics.
    Granneman GR; Braeckman RA; Locke CS; Cavanaugh JH; Dubé LM; Awni WM
    Clin Pharmacokinet; 1995; 29 Suppl 2():77-83. PubMed ID: 8620674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Griseofulvin and fluvoxamine interactions with the metabolism of theophylline.
    Rasmussen BB; Jeppesen U; Gaist D; Brøsen K
    Ther Drug Monit; 1997 Feb; 19(1):56-62. PubMed ID: 9029748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herb-drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats.
    Tang J; Sun J; Zhang Y; Li L; Cui F; He Z
    Food Chem Toxicol; 2007 Dec; 45(12):2441-5. PubMed ID: 17681658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.